Preethi Sundaram Catalyst Pharmaceuticals, Inc. (CPRX) insider trading activity
Preethi Sundaram is Chief Strategy Officer of CATALYST PHARMACEUTICALS, INC.. Currently has a direct ownership of 41,081 shares of CPRX, which is worth approximately $860,646. The most recent transaction as insider was on Jun 11, 2025, when has been sold 1,600 shares (Common Stock, par value $0.001 per share) at a price of $26.42 per share, resulting in proceeds of $42,272. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
41.1K
8.72%
3M change
60.84%
12M change
Total Value Held
$860,646
Preethi Sundaram Transaction History
PS
Preethi Sundaram
Chief Strategy Officer
Coral Gables, FL